United States-based medical devices and health care company Abbott (NYSE: ABT) announced on Friday that its board of directors declared a quarterly common dividend of USD0.59 per share.
This represents the 405th consecutive quarterly dividend since 1924. Payment is scheduled for 15 May 2025, to shareholders of record as of 15 April 2025.
Abbott has raised its dividend for 53 consecutive years. Inclusion in the S&P 500 Dividend Aristocrats Index reflects its commitment to annual dividend increases for over 25 years.
QT Imaging launches next-generation breast imaging reconstruction software
Tempus and Medtronic report positive ALERT trial results for AI-driven cardiac care
US FDA approves i-Lumen Scientific's i-SIGHT2 clinical study for dry AMD
Edwards Lifesciences reports positive two-year data for EVOQUE valve system
Clarity Pharmaceuticals signs copper-64 manufacturing agreement with Theragenics
Thermo Fisher Scientific and SHL Medical launch integrated US drug-device manufacturing
Philips launches integrated IntraSight Plus platform to enhance coronary intervention efficiency
Laronix and Greater Baltimore Medical Center launch Laronix MIRA Voice investigational study
BD receives CE Mark for Revello vascular covered stent
GAIA and Daiichi Sankyo Europe partner on digital therapeutic for cardiovascular care